Applied Clinical Trials Magazine

Our November issue is LIVE! Enhancing Empowerment in Patient-Focused Research??Addressing the Health Literacy Roadblock in Patient Recruitment??How to Balance Data and Trust??and so much more right here: https://lnkd.in/eWX3Gmbc

Happy Thanksgiving to all of our readers, experts, and clients! We're so thankful for all of the voices that help ACT be an authority in the industry. Looking forward to finishing out 2024 strong, and preparing for a fabulous 2025!

?? In this video interview, Jeff S., PhD, chief technology officer, Advarra, highlights how integration can simplify processes.

Data from the CAPItello-281 trial show Truqap alongside abiraterone and androgen deprivation therapy achieved a statistically significant and clinically meaningful improvement in radiographic progression-free survival.

Impact of FDA Project FrontRunner on Oncology Drug Development Learn about new pathways in cancer treatment through early access to investigational therapies. Join IQVIA’s Jeff Hodge, Patrick Brady, Jin Chen, MD, PhD, DABT, and David Cameron on December 10th as they cover pivotal strategies to enhance patient outcomes and accelerate FDA approval. Discover the leading methods for trial design, evidence generation, and regulatory engagement. Register now: https://lnkd.in/ehNZXPtj

The kinase inhibitor will be evaluated in patients with newly diagnosed #glioblastoma

To meet the growing demands of #clinicalresearch, sponsors must prioritize comprehensive support models, such as clinical site ambassadors and patient journey coordinators, who can address operational challenges and improve site relationships, patient satisfaction, and overall trial efficiency. ???Samantha Morley, Senior Manager, Clinical Monitoring; Danielle Shadforth, Clinical Monitoring Manager, FSP; and Nishma Patel, Senior Program Manager; all of Advanced Clinical

Even with advancements like electronic health records and AI, up to 80% of trials still miss enrollment timelines. While data helps identify potential participants, it doesn’t address the human side—why patients choose to join. For many, it comes down to trust. Strong relationships with physicians and research teams play a crucial role, especially in communities with a history of scepticism toward clinical trials. The best strategies combine both approaches: using data to target outreach and trust to foster meaningful connections. It’s about finding the right balance for each trial. How do you see data and trust shaping patient recruitment? TrialScreen CEO Hugo Stephenson explores this topic in Applied Clinical Trials Magazine. https://lnkd.in/graJ2Gzt

Cardiac Monitoring Reinvented: AI, Safety, and the Data Impact Tradition to transformational: AI and patient-centricity are inventing cardiac monitoring. In this live expert session with AliveCor, you'll discover why digital health technologies can improve your clinical trial data accuracy and operational efficiency. Register now: https://ow.ly/qY6h50Uaf5T

What learning science has taught us about the drivers and predictors of change—and applying those to clinical research practice ??? Brian S. McGowan, PhD, FACEHP, Chief Learning Officer and Co-Founder, ArcheMedX, Inc.